Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.
暂无分享,去创建一个
S. Agelaki | V. Georgoulias | J. Souglakos | S. Kakolyris | N. Vardakis | K. Kalbakis | L. Vamvakas | C. Kouroussis
暂无分享,去创建一个
S. Agelaki | V. Georgoulias | J. Souglakos | S. Kakolyris | N. Vardakis | K. Kalbakis | L. Vamvakas | C. Kouroussis